Literature DB >> 15762040

Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance.

E Diamanti-Kandarakis1, K Alexandraki, A Bergiele, H Kandarakis, G Mastorakos, A Aessopos.   

Abstract

This study was performed to determine whether phenotypically healthy sisters of women with polycystic ovary syndrome (PCOS) have evidence of insulin resistance. We studied 54 women: 17 with PCOS, 17 sisters of these probands and 20 control women with similar age, body mass index (BMI) and waist-to-hip ratio (WHR). The PCOS sisters had neither clinical nor laboratory evidence of hyperandrogenism. However, estimated insulin resistance indices indicated decreased insulin sensitivity in PCOS sisters compared with the controls. No difference of insulin resistance indices was detected between the PCOS and their sisters. This finding provides additional evidence that there is a hereditary trait regarding insulin resistance in the PCOS families.

Entities:  

Mesh:

Year:  2004        PMID: 15762040     DOI: 10.1007/BF03347535

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.

Authors:  B R Walker; A Rodin; N F Taylor; R N Clayton
Journal:  Clin Endocrinol (Oxf)       Date:  2000-01       Impact factor: 3.478

Review 2.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

3.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Authors:  C Weyer; P A Tataranni; C Bogardus; R E Pratley
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

4.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  Hyperinsulinemia is common in family members of women with polycystic ovary syndrome.

Authors:  R J Norman; S Masters; W Hague
Journal:  Fertil Steril       Date:  1996-12       Impact factor: 7.329

6.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.

Authors:  A H Carey; K L Chan; F Short; D White; R Williamson; S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1993-06       Impact factor: 3.478

8.  The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

Authors:  S Robinson; D Kiddy; S V Gelding; D Willis; R Niththyananthan; A Bush; D G Johnston; S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1993-09       Impact factor: 3.478

Review 9.  Phenotype and genotype in polycystic ovary syndrome.

Authors:  R S Legro; R Spielman; M Urbanek; D Driscoll; J F Strauss; A Dunaif
Journal:  Recent Prog Horm Res       Date:  1998

10.  Hemostatic and metabolic variables in women with polycystic ovary syndrome.

Authors:  E Dahlgren; P O Janson; S Johansson; L Lapidus; G Lindstedt; L Tengborn
Journal:  Fertil Steril       Date:  1994-03       Impact factor: 7.329

View more
  6 in total

Review 1.  Fetal programming of polycystic ovary syndrome.

Authors:  Esra Bahar Gur; Muammer Karadeniz; Guluzar Arzu Turan
Journal:  World J Diabetes       Date:  2015-07-10

2.  Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.

Authors:  A Priyadarshani
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

Review 3.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

4.  RESISTIN INHIBITS GLUCOSE-STIMULATED INSULIN SECRETION THROUGH MIR-494 BY TARGET ON STXBP5.

Authors:  F Wen; Y Yang; C Sun; H Fang; L Nie; L Li; Y Liu; Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

Review 5.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

Review 6.  Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome.

Authors:  Abm Kamrul-Hasan; Fatema Tuz Zahura Aalpona; Shahjada Selim
Journal:  touchREV Endocrinol       Date:  2021-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.